Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-31,000
Closed -$3.51M 24
2022
Q4
$3.51M Hold
31,000
1.52% 16
2022
Q3
$2.5M Buy
31,000
+8,000
+35% +$678K 1.13% 25
2022
Q2
$1.71M Buy
+23,000
New +$2.1M 0.72% 29

Other funds holding DXCM

Alpha Square Group S's DXCM Position: Q1 2023 in Review

Alpha Square Group S sold out of DexCom (DXCM) in Q1 2023, closing a stake of 31,000 shares — an estimated $3.51M sold.

Alpha Square Group S first reported a position in DXCM in Q2 2022 and held it in 3 quarters. The position peaked at $3.51M in Q4 2022. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Alpha Square Group S reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Alpha Square Group S sold 31,000 DexCom shares in Q1 2023, an estimated $3.51M.
  • Alpha Square Group S first reported a position in DexCom in Q2 2022 and held it in 3 quarters.
  • Alpha Square Group S's DexCom position peaked at $3.51M in Q4 2022.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Alpha Square Group S's 13F filing for Q1 2023, filed 15 May 2023.